Published in Obesity and Diabetes Week, September 5th, 2011
In a paper being published in Molecular Cell, Gladstone Senior Investigator Eric Verdin, MD, describes how SIRT3, when switched off, accelerates the build-up of fats throughout the body. This can lead to obesity, high blood pressure and a decreased ability to process sugar-the combination of which is known as the "metabolic syndrome." Metabolic syndrome significantly increases one's risk for developing heart disease and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week